Home › Research › Prevention and risk
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y et al.. The Lancet. Public health, 2020-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Findings Overall age-adjusted and sex-adjusted prevalence was estimated to be 6·0% (95% CI 5·8-6·3) for dementia, 3·9% (3·8-4·1) for Alzheimer's disease, 1·6% (1·5-1·7) for vascular dementia, and 0·5% (0·5-0·6) for other dementias. Overall MCI prevalence was estimated to be 15·5% (15·2-15·9), representing 38·77 million (37·95-39·62) people in China.
What this study adds
Evidence grade: Low
This is a cross-sectional study. This survey of adults aged 60 and over in China estimated that, after adjusting for age and sex, 6·0% had dementia (3·9% Alzheimer's disease, 1·6% vascular dementia and 0·5% other types). A further 15·5% had mild cognitive impairment, which the authors put at about 38·77 million people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., et al. (2020). Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet. Public health. https://doi.org/10.1016/s2468-2667(20)30185-7
Vancouver
Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet. Public health. 2020. doi:10.1016/s2468-2667(20)30185-7. PMID: 33271079.
BibTeX
@article{jia2020-33271079,
author = {Jia, L. and Du, Y. and Chu, L. and Zhang, Z. and Li, F. and Lyu, D. and Li, Y. and others},
title = {{Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study}},
journal = {The Lancet. Public health},
year = {2020},
doi = {10.1016/s2468-2667(20)30185-7},
pmid = {33271079},
url = {https://doi.org/10.1016/s2468-2667(20)30185-7}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Findings Overall age-adjusted and sex-adjusted prevalence was estimated to be 6·0% (95% CI 5·8-6·3) for dementia, 3·9% (3·8-4·1) for Alzheimer's disease, 1·6% (1·5-1·7) for vascular dementia, and 0·5% (0·5-0·6) for other dementias.
- Overall MCI prevalence was estimated to be 15·5% (15·2-15·9), representing 38·77 million (37·95-39·62) people in China.
Why it matters
This survey of adults aged 60 and over in China estimated that, after adjusting for age and sex, 6·0% had dementia (3·9% Alzheimer's disease, 1·6% vascular dementia and 0·5% other types). A further 15·5% had mild cognitive impairment, which the authors put at about 38·77 million people. It is a one-time snapshot of how common these conditions were, not a test of what causes or prevents them. The risk-factor and care findings named in its title are not in the summary we hold.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designcross-sectional
- Evidence strengthLow
How this study scored 60/100
Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (The Lancet. Public health) |
| Journal's citation record | 2 / 4 | The Lancet Public Health: journal h-index 155 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,761 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 220.1 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 6 / 6 | Cited 91.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 58 other studies in this library |
| Still being cited | 4 / 4 | Cited 1,193 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Qiongqiong Qiu: h-index 8 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Capital Medical University: institution h-index 643 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 20 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33271079) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 60 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/s2468-2667(20)30185-7
- PubMed: 33271079
- Original source →
- Free full text: thelancet.com →
Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 22.
Later studies that cite this one
58 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Prevention and risk from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.